• Home
    • Concept
  • Program
    • Scientific Board
    • Speakers
  • PneumoLive
  • Livestream
  • On-demand
  • Abstracts
  • Partners
  • Venue
  • Registration
  • Contacts
    • Data Privacy Policy
    • Legal Notice
info@medupdate-europe.eu
Login

Login
Pneumo Update Europe 2021Pneumo Update Europe 2021
Pneumo Update Europe 2021
25 - 26 June - Vienna & Virtual
  • Home
    • Concept
  • Program
    • Scientific Board
    • Speakers
  • PneumoLive
  • Livestream
  • On-demand
  • Abstracts
  • Partners
  • Venue
  • Registration
  • Contacts
    • Data Privacy Policy
    • Legal Notice

Partners

More Information

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Check here for more information about www.novartis.com

More Information

Boehringer Ingelheim has over 95 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.

Check here for more information about www.boehringer-ingelheim.com

More Information

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

Check here for more information about www.sanofi.com

More Information

Driven by innovative science and an entrepreneurial culture, AstraZeneca is focused on the delivery of life-changing medicines that are fuelling growth and contributing value to patients and society.

Check here for more information about www.astrazeneca.com

More Information

CSL Behring’s portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha-1 Antitrypsin Deficiency.

Check here for more information about www.cslbehring.com

Watch the 2020 Symposium here!

Looking for the 'zebras' among the horses in common respiratory disorders: could it be something else?

In cooperation with
Submit an Abstract pay only 250€! Register Here

Accreditation

The Pneumo Update Europe 2021 has applied for accreditation by the European Board for Accreditation in Pneumology (EBAP). EBAP reviewers have awarded the Mark of Excellence (MOE) for this activity in 2020. An MOE is given to activities with exceptionally high quality and standards.

The Pneumo Update Europe 2021 has applied for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME®) for European CME credits (ECMEC®s).

Follow us

ethical medtech

www.ethicalmedtech.eu

© 2021

  • Home
  • Legal Notice
  • Data Privacy Policy
  • Contacts
  • Cookie policy (EU)